LION: Climat Impact on Urinary Iodine Concentration

Sponsor
Swiss Federal Institute of Technology (Other)
Overall Status
Completed
CT.gov ID
NCT03215680
Collaborator
Ministry of Health, Tanzania (Other), North-West University, South Africa (Other)
363
2
17.7
181.5
10.2

Study Details

Study Description

Brief Summary

Urinary iodine concentration (UIC) is the recommended biomarker of iodine status in populations. Yet, the influence of climate on UIC remains unclear. Hot climate may reduce urine volume and consequently increase UIC independent of iodine status. This could lead to an overestimation of population iodine intake, thus masking iodine deficiency in vulnerable groups.

In this longitudinal observational cohort study in women of reproductive age we will collect 24h and spot urine samples in the summer and winter season. The influence of high temperature climates on UIC, measured and estimated urinary iodine excretion will be estimated.

Condition or Disease Intervention/Treatment Phase
  • Other: Climate

Study Design

Study Type:
Observational
Actual Enrollment :
363 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of Impact of High Temperature Climate on Urinary Iodine Concentration in Women of Reproductive Age
Actual Study Start Date :
Jul 10, 2017
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Tanzanian Women of Reproductive Age

Healthy women of reproductive age living in Tanzania in an area with hot and temperate climate

Other: Climate
Hot and temperate climate

South African Women of Reproductive Age

Healthy women of reproductive age living in South Africa in an area with hot and temperate climate

Other: Climate
Hot and temperate climate

Outcome Measures

Primary Outcome Measures

  1. Urinary iodine concentration [6 months]

    Measured in 24h urine collections

Secondary Outcome Measures

  1. Urinary iodine excretion [6 months]

    Measured in 24 h urine collections

Other Outcome Measures

  1. Urinary iodine concentration [6 months]

    Measured in spot urine samples

  2. Urinary iodine excretion [6 months]

    Measured in spot urine samples

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
  • Female

  • Non-pregnant and non-lactating

  • General good health, assessed by no reported treatment for chronic disease

  • Non-smoking

  • No known history of major medical illnesses or thyroid dysfunction as well as gastrointestinal or metabolic disorders and taking no chronic medication

  • Residence at the respective study site for 12 months or longer and no plans of moving away during the study year.

  • No use of iodine containing dietary supplements during the last 6 months

  • No use of X-ray / CT contrast agent or iodine containing medication within the last year

  • No use of iodine containing disinfectants during the last 6 months

  • Participants should be between 18 and 49 years at date of enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre of Excellence for Nutrition, Faculty of Health Science, North West University Potchefstroom South Africa
2 Ministry of Health, Community Development Gender, Elderly and Children Dar es Salaam Tanzania

Sponsors and Collaborators

  • Swiss Federal Institute of Technology
  • Ministry of Health, Tanzania
  • North-West University, South Africa

Investigators

  • Principal Investigator: Michael B Zimmermann, Prof. Dr., ETH Zurich

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof. Michael B. Zimmermann, Prof. Dr., Swiss Federal Institute of Technology
ClinicalTrials.gov Identifier:
NCT03215680
Other Study ID Numbers:
  • LION
First Posted:
Jul 12, 2017
Last Update Posted:
Mar 26, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prof. Michael B. Zimmermann, Prof. Dr., Swiss Federal Institute of Technology

Study Results

No Results Posted as of Mar 26, 2021